413 related articles for article (PubMed ID: 35173043)
21. Alterations in Polyamine Metabolism in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex 2-Deficient Cells.
Tang Y; El-Chemaly S; Taveira-Dasilva A; Goldberg HJ; Bagwe S; Rosas IO; Moss J; Priolo C; Henske EP
Chest; 2019 Dec; 156(6):1137-1148. PubMed ID: 31299246
[TBL] [Abstract][Full Text] [Related]
22. Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation.
Kim J; Jozic A; Lin Y; Eygeris Y; Bloom E; Tan X; Acosta C; MacDonald KD; Welsher KD; Sahay G
ACS Nano; 2022 Sep; 16(9):14792-14806. PubMed ID: 36038136
[TBL] [Abstract][Full Text] [Related]
23. Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM).
Goncharova EA; Goncharov DA; Fehrenbach M; Khavin I; Ducka B; Hino O; Colby TV; Merrilees MJ; Haczku A; Albelda SM; Krymskaya VP
Sci Transl Med; 2012 Oct; 4(154):154ra134. PubMed ID: 23035046
[TBL] [Abstract][Full Text] [Related]
24. Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA.
Tanaka H; Hagiwara S; Shirane D; Yamakawa T; Sato Y; Matsumoto C; Ishizaki K; Hishinuma M; Chida K; Sasaki K; Yonemochi E; Ueda K; Higashi K; Moribe K; Tadokoro T; Maenaka K; Taneichi S; Nakai Y; Tange K; Sakurai Y; Akita H
ACS Nano; 2023 Feb; 17(3):2588-2601. PubMed ID: 36719091
[TBL] [Abstract][Full Text] [Related]
25. Design of PD-L1-Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy.
Kim Y; Choi J; Kim EH; Park W; Jang H; Jang Y; Chi SG; Kweon DH; Lee K; Kim SH; Yang Y
Adv Sci (Weinh); 2024 Jun; 11(22):e2309917. PubMed ID: 38520717
[TBL] [Abstract][Full Text] [Related]
26. Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA.
Miao H; Huang K; Li Y; Li R; Zhou X; Shi J; Tong Z; Sun Z; Yu A
Int J Pharm; 2023 Jun; 640():123050. PubMed ID: 37201764
[TBL] [Abstract][Full Text] [Related]
27. A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA Delivery.
Naidu GS; Yong SB; Ramishetti S; Rampado R; Sharma P; Ezra A; Goldsmith M; Hazan-Halevy I; Chatterjee S; Aitha A; Peer D
Adv Sci (Weinh); 2023 Jul; 10(19):e2301929. PubMed ID: 37092557
[TBL] [Abstract][Full Text] [Related]
28. Rapamycin-resistant poly (ADP-ribose) polymerase-1 overexpression is a potential therapeutic target in lymphangioleiomyomatosis.
Sun Y; Gallacchi D; Zhang EY; Reynolds SB; Robinson L; Malinowska IA; Chiou TT; Pereira AM; Li C; Kwiatkowski DJ; Lee PS; Yu JJ
Am J Respir Cell Mol Biol; 2014 Dec; 51(6):738-49. PubMed ID: 24874429
[TBL] [Abstract][Full Text] [Related]
29. Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System.
Pattipeiluhu R; Arias-Alpizar G; Basha G; Chan KYT; Bussmann J; Sharp TH; Moradi MA; Sommerdijk N; Harris EN; Cullis PR; Kros A; Witzigmann D; Campbell F
Adv Mater; 2022 Apr; 34(16):e2201095. PubMed ID: 35218106
[TBL] [Abstract][Full Text] [Related]
30. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
31. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique
Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ
Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076
[TBL] [Abstract][Full Text] [Related]
32. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery.
Wang X; Liu S; Sun Y; Yu X; Lee SM; Cheng Q; Wei T; Gong J; Robinson J; Zhang D; Lian X; Basak P; Siegwart DJ
Nat Protoc; 2023 Jan; 18(1):265-291. PubMed ID: 36316378
[TBL] [Abstract][Full Text] [Related]
33. Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets.
Conway A; Mendel M; Kim K; McGovern K; Boyko A; Zhang L; Miller JC; DeKelver RC; Paschon DE; Mui BL; Lin PJC; Tam YK; Barbosa C; Redelmeier T; Holmes MC; Lee G
Mol Ther; 2019 Apr; 27(4):866-877. PubMed ID: 30902585
[TBL] [Abstract][Full Text] [Related]
34. Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting.
Sakurai Y; Mizumura W; Murata M; Hada T; Yamamoto S; Ito K; Iwasaki K; Katoh T; Goto Y; Takagi A; Kohara M; Suga H; Harashima H
Mol Pharm; 2017 Oct; 14(10):3290-3298. PubMed ID: 28789523
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E Binding Drives Structural and Compositional Rearrangement of mRNA-Containing Lipid Nanoparticles.
Sebastiani F; Yanez Arteta M; Lerche M; Porcar L; Lang C; Bragg RA; Elmore CS; Krishnamurthy VR; Russell RA; Darwish T; Pichler H; Waldie S; Moulin M; Haertlein M; Forsyth VT; Lindfors L; Cárdenas M
ACS Nano; 2021 Apr; 15(4):6709-6722. PubMed ID: 33754708
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and bioactivity of readily hydrolysable novel cationic lipids for potential lung delivery application of mRNAs.
Pei Y; Bao Y; Sacchetti C; Brady J; Gillard K; Yu H; Roberts S; Rajappan K; Tanis SP; Perez-Garcia CG; Chivukula P; Karmali PP
Chem Phys Lipids; 2022 Mar; 243():105178. PubMed ID: 35122738
[TBL] [Abstract][Full Text] [Related]
37. mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo.
Rybakova Y; Kowalski PS; Huang Y; Gonzalez JT; Heartlein MW; DeRosa F; Delcassian D; Anderson DG
Mol Ther; 2019 Aug; 27(8):1415-1423. PubMed ID: 31160223
[TBL] [Abstract][Full Text] [Related]
38. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications.
Jeong M; Lee Y; Park J; Jung H; Lee H
Adv Drug Deliv Rev; 2023 Sep; 200():114990. PubMed ID: 37423563
[TBL] [Abstract][Full Text] [Related]
39. Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA).
Álvarez-Benedicto E; Farbiak L; Márquez Ramírez M; Wang X; Johnson LT; Mian O; Guerrero ED; Siegwart DJ
Biomater Sci; 2022 Jan; 10(2):549-559. PubMed ID: 34904974
[TBL] [Abstract][Full Text] [Related]
40. Progesterone and estradiol synergistically promote the lung metastasis of tuberin-deficient cells in a preclinical model of lymphangioleiomyomatosis.
Sun Y; Zhang E; Lao T; Pereira AM; Li C; Xiong L; Morrison T; Haley KJ; Zhou X; Yu JJ
Horm Cancer; 2014 Oct; 5(5):284-98. PubMed ID: 25069840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
